Stryker named Nick Mead as its vice president of investor relations, according to a March 31 news release. Mr. Mead replaces Jason Beach, who was promoted to vice president, group CFO of Stryker’s MedSurg and Neurotechnology divisions. Mr. Mead has…
Spinal Tech
Medtronic has started 2026 strong in the first quarter with new FDA clearances and growth in the market. Here are five headlines to know: 1. Medtronic earned the FDA’s 510(k) clearance for its Stealth AXiS system that brings planning, navigation…
Medtronic’s Stealth AXiS surgical system has earned FDA clearance for cranial as well as ear, nose and throat procedures. The Stealth system combines surgical planning, navigation and robotics into a single intelligent system to improve surgeon precision, according to a…
SpinePoint earned the FDA’s 510(k) clearance for its Flex-Z cervical cage, according to a March 27 news release shared with Becker’s. The Flex-Z cage is designed to address stiffness mismatches between conventional interbody implants and vertebral bone. It’s made with…
Stryker CEO Kevin Lobo’s total compensation was $21.4 million in 2025, according to a recent Securities and Exchange Commission proxy filing. The devicemaker’s March 23 filing revealed the compensation packages for five executives from 2023 to 2025. Compensation packages include salary,…
Advertisement
John DeFord, PhD, is stepping down from Globus Medical’s board of directors, according to a March 23 news release. His departure was effective immediately, the company said. “We are grateful for John’s many contributions, especially during the merger with NuVasive…
VySpine earned FDA 510(k) clearance for its DiversiVy facet screw, according to a March 23 news release. DiversiVy is designed for the lumbosacral spine to aid in fusions. It is indicated for posterior surgical treatment with or without bone graft…
Spine and orthopedic companies inked key deals in the first quarter of 2026. 1. VB Spine has entered into an agreement with Robotron Surgical Technologies to acquire the SpineHawk platform. 2. VB Spine entered a definitive agreement to acquire exclusive rights to Augmedics’ xvision…
Providence Medical Technology enrolled its first patients for a randomized controlled trial for its Corus-LX system for degenerative lumbosacral disease, according to a March 19 news release. The multicenter trial will focus on patients who qualify for two-level interbody fusion…
Spinal Elements earned FDA 510(k) clearance for its Ventana A anterior lumbar interbody fusion system, and A.J. Rush, MD, debuted the device, according to a March 18 news release. Dr. Rush performed the first case using the Ventana A system…